Davidar David D
SEC Form 4 insider trading activity
Davidar David D has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Jul 28, 2026.
On the most recent filing, Davidar David D is listed as Director at GLOBUS MEDICAL INC. Inside the rolling window, Davidar David D reported no open-market purchases and 2 open-market sales totaling $4.2M in GMED. The largest disclosed transaction in the window is a sale of 25,000 GMED shares on Nov 12, 2025, worth $2.2M.
Companies traded
Other insiders at GMED
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$4.2M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Davidar David D made?
Davidar David D has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does Davidar David D trade?
Davidar David D has filed SEC Form 4 disclosures for 1 company, including GMED.
When was Davidar David D's most recent SEC Form 4 filing?
Davidar David D's most recent SEC Form 4 filing on Tracefour is dated Jul 28, 2026.
What is Davidar David D's total buy and sell value in the current window?
Inside the rolling retention window, Davidar David D bought $0 and sold $4.2M based on SEC Form 4 filings.
What was Davidar David D's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 25,000 GMED shares on 2025-11-12, worth $2.2M, per SEC Form 4 filings.